Quantcast
Channel: WN.com - Articles related to Preclinical Data of Xencor's XmAb Bispecific Technology to be Presented at Upcoming ASH Annual Meeting
Viewing all articles
Browse latest Browse all 614

Global Market Study on Next-Generation Antibody Therapeutics: Biosimilar Antibody Products to Witness Highest Growth by 2022 - Reportlinker Review

$
0
0
NEW YORK, Nov. 5, 2015 /PRNewswire/ -- Next-generation antibody therapeutics refer to the improved antibody therapeutics with enhanced efficiency, greater safety, and improved delivery. Next-generation antibody-based therapeutics overcome the limitations of monoclonal antibodies and feature enhancements to existing properties of therapeutic antibodies. Various biotechnology and biopharmaceutical companies are actively involved in development of next-generation antibody therapeutics, especially...

Viewing all articles
Browse latest Browse all 614

Trending Articles



<script src="https://jsc.adskeeper.com/r/s/rssing.com.1596347.js" async> </script>